XML 20 R9.htm IDEA: XBRL DOCUMENT v3.7.0.1
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
6 Months Ended
Jun. 30, 2017
Jun. 30, 2016
Operating Activities    
Net income $ 97,385 $ 67,432
Adjustments to reconcile net income to net cash flows provided by operating activities:    
Depreciation, amortization and accretion 36,392 25,892
Provision for credit losses 27,606 28,408
Deferred tax expense 21,226 11,539
Net securities gains (3,118) (297)
Tax benefit of stock-based compensation (724) (143)
Loans originated for sale (519,973) (266,597)
Loans sold 380,522 263,112
Gain on sale of loans (4,716) (3,797)
Net change in:    
Interest receivable (462) (215)
Interest payable 58 (131)
Bank owned life insurance (5,063) (3,355)
Other, net (114,988) (21,916)
Net cash flows (used in) provided by operating activities (85,855) 99,932
Investing Activities    
Net change in loans and leases (582,236) (438,448)
Securities available for sale:    
Purchases (592,601) (622,544)
Sales 755,866 615,199
Maturities 247,930 256,722
Securities held to maturity:    
Purchases (782,281) (588,138)
Sales 1,574 0
Maturities 214,739 158,240
Purchase of bank owned life insurance (5,805) (16,579)
Increase in premises and equipment (34,832) (27,311)
Net cash received in business combinations 196,964 245,762
Net cash flows used in investing activities (580,682) (417,097)
Financing Activities    
Demand (non-interest bearing and interest bearing) and savings accounts (45,049) 355,565
Time deposits (143,154) (79,850)
Short-term borrowings 1,126,769 9,114
Proceeds from issuance of long-term borrowings 77,223 28,168
Repayment of long-term borrowings (133,162) (37,942)
Net proceeds from issuance of common stock 3,702 6,603
Tax benefit of stock-based compensation 0 143
Cash dividends paid:    
Preferred stock (4,020) (4,020)
Common stock (64,561) (50,708)
Net cash flows provided by financing activities 817,748 227,073
Net Increase (Decrease) in Cash and Cash Equivalents 151,211 (90,092)
Cash and cash equivalents at beginning of period 371,407 489,119
Cash and Cash Equivalents at End of Period $ 522,618 $ 399,027